Barry M. Deutsch - Net Worth and Insider Trading

Barry M. Deutsch Net Worth

The estimated net worth of Barry M. Deutsch is at least $75,963 dollars as of 2024-05-27. Barry M. Deutsch is the See Remarks of Xeris Biopharma Holdings Inc and owns about 39,359 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $75,963. Details can be seen in Barry M. Deutsch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barry M. Deutsch has not made any transactions after 2020-02-14 and currently still holds the listed stock(s).

Transaction Summary of Barry M. Deutsch

To

Barry M. Deutsch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barry M. Deutsch owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .

Click here to see the complete history of Barry M. Deutsch’s form 4 insider trades.

Insider Ownership Summary of Barry M. Deutsch

Ticker Comapny Transaction Date Type of Owner
XERS Xeris Biopharma Holdings Inc 2020-08-14 See Remarks

Barry M. Deutsch Latest Holdings Summary

Barry M. Deutsch currently owns a total of 1 stock. Barry M. Deutsch owns 39,359 shares of Xeris Biopharma Holdings Inc (XERS) as of February 14, 2020, with a value of $75,963.

Latest Holdings of Barry M. Deutsch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XERS Xeris Biopharma Holdings Inc 2020-02-14 39,359 1.93 75,963

Holding Weightings of Barry M. Deutsch


Barry M. Deutsch Form 4 Trading Tracker

According to the SEC Form 4 filings, Barry M. Deutsch has made a total of 1 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 9,639 shares on February 14, 2020, which cost Barry M. Deutsch around $40,002.

Insider Trading History of Barry M. Deutsch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Barry M. Deutsch Trading Performance

GuruFocus tracks the stock performance after each of Barry M. Deutsch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barry M. Deutsch is 7.75%. GuruFocus also compares Barry M. Deutsch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barry M. Deutsch within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Barry M. Deutsch's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Barry M. Deutsch

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.65
Relative Return to S&P 500(%) -9.7

Barry M. Deutsch Ownership Network

Ownership Network List of Barry M. Deutsch

No Data

Ownership Network Relation of Barry M. Deutsch


Barry M. Deutsch Owned Company Details

What does Xeris Biopharma Holdings Inc do?

Who are the key executives at Xeris Biopharma Holdings Inc?

Barry M. Deutsch is the See Remarks of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .

Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary

Over the past 18 months, Barry M. Deutsch made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 16,400 shares made by John P. Schmid , a net purchase of 30,000 shares made by Paul R Edick , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 9,900 shares, with a net purchase of 9,900 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 115,979 shares were bought by its insiders, resulting in a net purchase of 115,979 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xeris Biopharma Holdings Inc Insider Transactions

No Available Data

Barry M. Deutsch Mailing Address

Above is the net worth, insider trading, and ownership report for Barry M. Deutsch. You might contact Barry M. Deutsch via mailing address: Ovation Pharmaceuticals, Inc. Four Parkway North, Suite 200 Deerfield Il 60015.

Discussions on Barry M. Deutsch

No discussions yet.